Table 7: Eye Exam and Treatment in Patients with Glaucomatous Optic Neuropathy.
Findings on eye exam, testing results, and treatment of patients with glaucomatous optic neuropathy as broken down by presence of metabolic syndrome.
| Unadjusted analysis | Adjusting for age, sex, race (white vs. non-white), and smoking history | ||||||||
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| Association between metabolic syndrome and: | N | Median (minimum, maximum) or No. (%) for the given group | N | Association measure | Estimate (95% CI) | P-value | Estimate (95% CI) | P-value | |
|
| |||||||||
| No Metabolic Syndrome | Metabolic Syndrome | ||||||||
| VA OD (0.1 logMAR unit) | 351 | 0.0 (−0.1, 1.0) | 993 | 0.0 (−0.1, 5.0) | Odds ratio | 1.43 (1.26, 1.62) | <0.01 | 1.19 (1.06, 1.35) | <0.01 |
| VA OS (0.1 logMAR unit) | 351 | 0.0 (−0.1, 0.5) | 995 | 0.0 (−0.1, 5.0) | Odds ratio | 1.43 (1.26, 1.62) | <0.01 | 1.19 (1.05, 1.34) | <0.01 |
| VA mean (0.1 logMAR unit) | 351 | 0.0 (−0.1, 0.7) | 989 | 0.1 (−0.1, 4.0) | Odds ratio | 1.55 (1.34, 1.79) | <0.01 | 1.25 (1.09, 1.44) | <0.01 |
| IOP OD (5 mmHg) | 661 | 15.0 (4.0, 35.0) | 3802 | 15.0 (2.0, 76.0) | Odds ratio | 1.01 (0.92, 1.11) | 0.81 | 1.21 (1.07, 1.37) | <0.01 |
| IOP OS (5 mmHg) | 665 | 15.0 (2.0, 30.0) | 3808 | 15.0 (0.0, 68.0) | Odds ratio | 0.97 (0.88, 1.07) | 0.55 | 1.18 (1.05, 1.33) | <0.01 |
| IOP mean (5 mmHg) | 660 | 15.0 (3.5, 30.0) | 3785 | 15.0 (2.5, 63.0) | Odds ratio | 0.99 (0.89, 1.10) | 0.81 | 1.23 (1.08, 1.40) | <0.01 |
| C:D OD (0.10) | 652 | 0.60 (0.00, 1.00) | 3831 | 0.65 (0.00, 1.00) | Odds ratio | 1.06 (1.02, 1.10) | <0.01 | 0.99 (0.95, 1.04) | 0.69 |
| C:D OS (0.10) | 653 | 0.60 (0.00, 1.00) | 3849 | 0.65 (0.00, 1.00) | Odds ratio | 1.07 (1.03, 1.11) | <0.01 | 1.00 (0.96, 1.04) | 0.93 |
| C:D mean (0.10) | 648 | 0.60 (0.00, 1.00) | 3797 | 0.65 (0.00, 1.00) | Odds ratio | 1.08 (1.04, 1.12) | <0.01 | 1.00 (0.95, 1.05) | 0.92 |
| Total Number of Drops | 682 | 3971 | Odds ratio | 1.29 (1.18, 1.40) | <0.01 | 1.08 (0.99, 1.18) | 0.08 | ||
| 0 | 471 (69.1%) | 2228 (56.1%) | |||||||
| 1 | 100 (14.7%) | 795 (20.0%) | |||||||
| 2 | 62 (9.1%) | 459 (11.6%) | |||||||
| 3 | 38 (5.6%) | 324 (8.2%) | |||||||
| 4 | 11 (1.6%) | 155 (3.9%) | |||||||
| 5 | 0 (0.0%) | 10 (0.3%) | |||||||
| Drops 1+ | 682 | 211 (30.9%) | 3971 | 1743 (43.9%) | Odds ratio | 1.75 (1.47, 2.08) | <0.01 | 1.20 (0.99, 1.45) | 0.07 |
| Incisional Glaucoma Surgery | 682 | 40 (5.9%) | 3971 | 333 (8.4%) | Odds ratio | 1.47 (1.05, 2.06) | 0.03 | 1.07 (0.74, 1.53) | 0.73 |
| Minor Glaucoma Procedure | 682 | 48 (7.0%) | 3971 | 373 (9.4%) | Odds ratio | 1.37 (1.00, 1.87) | <0.05 | 1.08 (0.77, 1.50) | 0.66 |
| CCT OD (20 μm) | 306 | 551.5 (435.0, 649.0) | 1841 | 557.0 (409.0, 740.0) | Odds ratio | 1.07 (1.01, 1.14) | 0.03 | 1.09 (1.02, 1.17) | 0.01 |
| CCT OS (20 μm) | 307 | 554.0 (440.0, 658.0) | 1840 | 558.0 (379.0, 812.0) | Odds ratio | 1.07 (1.00, 1.13) | 0.04 | 1.09 (1.02, 1.16) | 0.01 |
| CCT mean (20 μm) | 305 | 553.0 (437.5, 647.0) | 1834 | 557.3 (394.0, 718.5) | Odds ratio | 1.07 (1.00, 1.14) | 0.04 | 1.09 (1.02, 1.17) | 0.01 |
| VFMD OD (1 dB) | 138 | 0.2 (−20.3, 4.3) | 412 | −0.5 (−29.2, 3.3) | Odds ratio | 0.94 (0.90, 0.99) | 0.01 | 0.97 (0.92, 1.02) | 0.29 |
| VFMD OS (1 dB) | 139 | −0.4 (−27.0, 2.9) | 408 | −0.9 (−30.0, 5.0) | Odds ratio | 0.95 (0.90, 0.99) | 0.02 | 0.97 (0.92, 1.02) | 0.26 |
| VFMD mean (1 dB) | 138 | −0.2 (−16.3, 3.1) | 406 | −0.7 (−27.5, 3.7) | Odds ratio | 0.93 (0.89, 0.98) | 0.01 | 0.97 (0.91, 1.03) | 0.26 |
| RNFL OD (10 μm) | 207 | 83.0 (50.0, 147.0) | 1057 | 79.0 (37.0, 133.0) | Odds ratio | 0.78 (0.70, 0.88) | <0.01 | 0.97 (0.85, 1.10) | 0.61 |
| RNFL OS (10 μm) | 208 | 83.0 (50.0, 143.0) | 1061 | 78.0 (30.0, 124.0) | Odds ratio | 0.78 (0.70, 0.87) | <0.01 | 0.89 (0.79, 1.01) | 0.07 |
| RNFL mean (10 μm) | 207 | 82.5 (56.0, 123.5) | 1048 | 78.0 (41.0, 126.0) | Odds ratio | 0.74 (0.66, 0.84) | <0.01 | 0.91 (0.60, 1.05) | 0.20 |
CI=confidence interval. Logistic regression model.
VA and VFMD analyses exclude patients with cataract, macular degeneration, other forms of optic neuropathy, retinal vascular occlusion, and proliferative diabetic retinopathy
RNFL analysis excludes patients with other forms of optic neuropathy, retinal vascular occlusion, and proliferative diabetic retinopathy